Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
From - G2 Compliance Advisor
Labs need to use the power of data to make compliance programs more focused, efficient and successful. Take a lesson from…
From - Diagnostic Testing & Emerging Technologies
In mid-July, the Senate Finance Committee heard testimony from stakeholders arguing for changes to the Stark Law that could make compliance easier and…